Wird geladen...
PHASE III STUDY OF RADIATION THERAPY WITH OR WITHOUT CIS-PLATINUM IN PATIENTS WITH UNRESECTABLE SQUAMOUS OR UNDIFFERENTIATED CARCINOMA OF THE HEAD AND NECK: AN INTERGROUP TRIAL OF THE EASTERN COOPERATIVE ONCOLOGY GROUP (E2382)
PURPOSE: The Head and Neck Intergroup conducted a Phase III randomized trial to determine whether the addition weekly cisplatin to daily radiation therapy (RT) would improve survival in patients with unresectable squamous cell head-and-neck carcinoma. METHODS AND MATERIALS: Eligible patients were ra...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3612971/ https://ncbi.nlm.nih.gov/pubmed/20888709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.06.038 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|